A recent report published by Infinium Global Research on cryptococcosis market provides in-depth analysis of segments and sub-segments in the global as well as regional cryptococcosis market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional cryptococcosis market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global cryptococcosis market. According to the report, the global cryptococcosis market is projected to grow at a CAGR of 5.1% over the forecast period of 2019-2025.
Cryptococcosis is an opportunistic infection caused by fungi that occur primarily among people with advanced HIV disease. Cryptococcosis is an important cause of morbidity and mortality. Risk factors for cryptococcosis include AIDS, Hodgkin lymphoma, other lymphomas, Sarcoidosis, and Solid organ transplantation. Cryptococcosis is mainly acquired by inhalation and that typically affects the lungs. Cryptococcosis symptoms include fever, malaise, pleuritic chest pain, cough, hemoptysis, and headache. Cryptococcosis treatment consists of three phases that include induction, consolidation, and maintenance therapy. The diagnosis of cryptococcosis can be made by microscopic examination and culture of tissue or body fluids that include blood, cerebrospinal fluid, and sputum.
The key factor that drives the growth of cryptococcosis is the growing prevalence of cryptococcosis diseases market. According to the WHO, it is estimated that 223 100 cases of cryptococcal meaning it results in 181 000 deaths each year among PLHIV. In addition, the several governments and the non-government organizations are taking initiative to provide awareness about the cryptococcosis that is contributing to the growth of cryptococcosis market. Furthermore, The Potential advantages of the pulmonary route as an alternative to oral and parenteral delivery methods are anticipated to promote the growth of cryptococcosis market in the near future. On the other hand, less awareness regarding pulmonary drugs delivery is expected to restrain the growth of cryptococcosis market. Moreover, increasing government initiatives to provide new and advanced treatments are projected to create several opportunities in the cryptococcosis market over the forecast period.
Among the geographies, North America holds the maximum market share in the cryptococcosis market owing to the high prevalence of infectious diseases. The developed healthcare infrastructure and favorable government policies are contributing to the growth of cryptococcosis market in the North America region. Additionally, Sub-Sahara African countries hold a significant share in the cryptococcosis market owing to the high prevalence of HIV patients and low awareness about cryptococcosis treatments. Furthermore, Asia Pacific is the fastest growing region in the cryptococcosis market. The developing healthcare infrastructure and growing occurrence of lung disease are expected to serve various opportunities for the Asia Pacific cryptococcosis market in the year to come.
The report on global cryptococcosis market covers segments such as treatment and distribution channel. On the basis of treatment, the sub-markets include flucytosine, amphotericin B, fluconazole, and others. On the basis of the distribution channel, the sub-markets include retail pharmacies, mail order pharmacies, drug store, hospital pharmacies, and others.
The report provides profiles of the companies in the market such as Pfizer Inc., Janssen Biotech, Inc., Bristol-Myers Squibb Company, Sigmapharm Laboratories, LLC, Novartis AG, Abbott Laboratories, Janssen Global Services, LLC, Alkopharma Inc, and Others.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of cryptococcosis market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Cryptococcosis Market Highlights
2.2. Cryptococcosis Market Projection
2.3. Cryptococcosis Market Regional Highlights
3. Global Cryptococcosis Market Overview
3.2. Market Dynamics
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Treatment
3.4.2. IGR-Growth Matrix Analysis by Distribution Channel
3.4.3. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Cryptococcosis Market
4. Cryptococcosis Market Macro Indicator Analysis
5. Global Cryptococcosis Market by Treatment
5.2. Amphotericin B
6. Global Cryptococcosis Market by Distribution Channel
6.1. Retail Pharmacies
6.2. Mail Order Pharmacies
6.3. Drug Store
6.4. Hospital Pharmacies
7. Global Cryptococcosis Market by Region 2019-2025
7.1. North America
7.1.1. North America Cryptococcosis Market by Treatment
7.1.2. North America Cryptococcosis Market by Distribution Channel
7.1.3. North America Cryptococcosis Market by Country
7.2.1. Europe Cryptococcosis Market by Treatment
7.2.2. Europe Cryptococcosis Market by Distribution Channel
7.2.3. Europe Cryptococcosis Market by Country
7.3.1. Asia-Pacific Cryptococcosis Market by Treatment
7.3.2. Asia-Pacific Cryptococcosis Market by Distribution Channel
7.3.3. Asia-Pacific Cryptococcosis Market by Country
7.4.1. RoW Cryptococcosis Market by Treatment
7.4.2. RoW Cryptococcosis Market by Distribution Channel
7.4.3. RoW Cryptococcosis Market by Sub-region
8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Cryptococcosis Market
8.2. Companies Profiles
8.2.1. Pfizer Inc.
8.2.2. Janssen Biotech, Inc.
8.2.3. Bristol-Myers Squibb Company
8.2.4. Sigmapharm Laboratories, LLC
8.2.5. Novartis AG
8.2.6. Abbott Laboratories
8.2.7. Janssen Global Services, LLC,
8.2.8. Alkopharma Inc
9.1. Primary Research Findings and Questionnaire
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.
sign up for our newsletter